Podcasts about RETAIN

Every single day, there are news stories about artificial intelligence (AI)—most notably, controversies about unethical practices by companies that offer AI services—so independent publishers are trying to determine if using AI is the right fit for their businesses.Author and Indie Author Magazine Co-Founder and Publisher Chelle Honiker joins “Inside Independent Publishing (with IBPA)” to share her expertise on the subject, including the ethical concerns about using AI, what the most effective AI platforms are for publishers, how AI can be used to help publishers run their businesses more efficiently, and much more.PARTICIPANTSChelle Honiker is the co-founder and publisher of Indie Author Magazine, IndieAuthorTraining, Indie Author Tools, and Direct2Readers.com. Her team of more than 80 writers, editors, trainers, and support staff provides resources and insights that help authors navigate the complexities of self-publishing. Her role as the programming director for Author Nation, an annual conference in Las Vegas, further exemplifies her commitment to fostering a community where authors can grow and succeed.With a career spanning over two decades in executive operations and leadership, Chelle has honed her skills in managing complex projects and delivering impactful training programs. Her experience as a speaker and TEDx Organizer has taken her to many countries, where she has shared her insights with diverse audiences.Independent Book Publishers Association is the largest trade association for independent publishers in the United States. As the IBPA Director of Membership & Member Services, Christopher Locke assists the 4,000 members as they travel along their publishing journeys. Major projects include managing the member benefits to curate the most advantageous services for independent publishers and author publishers; managing the Innovative Voices Program that supports publishers from marginalized communities; and hosting the IBPA podcast, “Inside Independent Publishing (with IBPA).” He's also passionate about indie publishing, because he's an author publisher himself, having published two novels so far in his YA trilogy, The Enlightenment Adventures.LINKSLearn more about the many benefits of becoming a member of Independent Book Publishers Association (IBPA) here: https://www.ibpa-online.org/Check out Chelle Honiker's books at https://chellehoniker.com/Also, learn more about Indie Author Magazine at https://indieauthormagazine.com/Follow IBPA on:Facebook – https://www.facebook.com/IBPAonlineX – https://twitter.com/ibpaInstagram - https://www.instagram.com/ibpalovesindies/Today's episode is presented by Gatekeeper Press — where authors are family. Gatekeeper Press empowers indie authors with expert publishing, editing, and global distribution services—providing full, white-glove concierge support every step of the way. Retain 100% of your rights, royalties, and creative control at gatekeeperpress.com.

In this episode of the Dibbly Dobbly Podcast we review the third Ashes series between Australia vs England.Time Stamps0:00 Intro2:24 Score Recap4:08 Match Summary6:01 AUS Analysis49:19 ENG Analysis1:11:46 Fourth Ashes Test Preview1:29:20 Final Thoughts1:32:14 OutroDibbly Dobbly Podcast Patreon Linkhttps://www.patreon.com/DibblyDobblyPodcastSocial MediaFacebook Page: https://www.facebook.com/DibblyDobblyPodcastTwitter Page: https://twitter.com/dibblydobblypodInstagram Page: https://www.instagram.com/dibblydobblypodcast/Podcast ServicesAnchor: https://anchor.fm/dibblydobblypodcast Spotify: https://open.spotify.com/show/1Bq4N1bCSesF5L9jsY6wP4 Apple Podcasts: https://podcasts.apple.com/us/podcast/dibbly-dobbly-podcast/id1596733214Blogger Pagehttp://dibblydobblypodcast.blogspot.comSubstack Pagehttps://dibbly.substack.com

In this episode, we talk about Bazball.Its merits, demerits ,and how it all came crashing down because of very little planning and even poor execution.We also talk briefly about the Indian T20 squad for the upcoming T20 WC and what happened with the axing of Shubman Gill?

England showed plenty of fight but Australia won the 3rd Test by 82 runs to retain the Ashes with two games to spare, We hear from England coach Brendon McCullum and captain Ben Stokes as well as Australia skipper Pat Cummins, Player of the match Alex Carey plus Mitchell Starc. Marnus Labuschagne and Travis Head. There's also analysis by Jonathan Agnew, Simon Mann, Glenn McGrath, Phil Tufnell and Andy Zaltzman.

Cam and Yas on the day that Australia retained the urn despite resistance from Will Jacks and Jamie Smith on the final day in Adelaide.

Nas and Ath are in the empty stands at the Adelaide Oval an hour after England lost The Ashes. Australia beat England by 82 runs on the final day of the third Test, to take an unassailable 3-0 series lead. How did England get here? We'll have more reflections on where The Ashes were lost on Tuesday, so make sure you give this show a follow wherever you listen to your podcasts so you don't miss out. Watch every episode of the Sky Sports Cricket Podcast on YouTube here: Sky Sports Cricket Podcast on YouTubeListen to every episode of the Sky Sports Cricket Podcast here: skysports.com/sky-sports-cricket-podcastYou can listen to the Sky Sports Cricket Podcast on your smart speaker by saying "ask Global Player to play Sky Sports Cricket Podcast".Join in the debate on Twitter @SkyCricket.For all the latest Cricket news, head to skysports.com/cricketFor advertising opportunities or to get in touch with the pod email: skysportspodcasts@sky.uk

Australia sealed the Ashes in Adelaide by staying patient long enough for England to defeat themselves.For a moment on day five, with wickets in hand and runs still on the board, the chase felt alive. But Australia never panicked and, as Ed Cowan explains, every time England edged towards belief, they handed momentum straight back.England played their best cricket when they showed restraint, and lost it when they didn't.Australia trusted time, conditions, and discipline, waited for the mistakes, and closed out the series without needing to force the result. The composure of this Australian squad stood out again, with Pat Cummins setting the tone with calm leadership, Scott Boland finishing with relentless discipline, and Marnus Labuschagne finding ways to influence the game beyond the bat.ABC Grandstand cricket commentator Corbin Middlemas is joined by Ed Cowan to bring you all the highlights and match analysis to keep you up to speed. The pair discuss the key players and big issues that are dominating the cricket agenda. Whether it's Ashes results, the latest in live fixtures or you just need a hit of cricket banter.Catch every episode of ‘The ABC Cricket Podcast,' hosted by Corbin Middlemas on ABC listen or wherever you get your podcasts, and get in touch with them on social media via @abc_sport This podcast was formerly known as ‘The Grandstand Cricket Podcast'

Australia retains The Ashes with an unassailable lead in the series as it secures the win in Adelaide. 

Australia has retained the Ashes in record-breaking time, and Queensland legend Ryan Harris joins the show to dismantle the "stupid" pre-series comments from Stuart Broad and Piers Morgan.See omnystudio.com/listener for privacy information.

Just like that, in 11 days the Aussies have demolished the Poms and retained the Ashes 3-0. It has been a dominant display across these 3 tests with England not really firing a shot. Listen along as Tricky grills the England Cricket Team and Media with their Pre Series Predictions to what they put out there!!We also cover such topics such as: - Ollie Pope - Harry Brook - Is Cameron Green in the hot water - Usman Khawaja's place in this time +more.

As Kiwi's flock to the beaches in the summer heat, the need for surf lifeguards couldn't be greater. But Surf Life Saving New Zealand says that with the growing population, they'll need 1000 volunteers over the next three years, especially at Auckland's wild west coast beaches. One of those popular black-sand beaches, Bethell's, has been identified by Water Safety New Zealand as one of the country's drowning blackspots. But with its club house still yellow-stickered after Cyclone Gabrielle, they're struggling to retain some volunteers they need to keep people safe in the water. Bella Craig reports.

How can leaders maximize attract great talent and maximize on the talent they already have?Meet Dr. Cynthia Bentzen-Mercer!Dr. Cynthia is a Human Capital Potentialist who works at the intersection of organizational strategy and soul purpose. She is a globally recognized human capital strategist, USA Today bestselling author, and board-certified executive coach with more than 30 years of experience transforming how organizations invest in their people. As the founder and CEO of Bentzen Performance Partners, co-founder of The Zeal of the Heel, and creator of the 7 Minute Pivot, she partners with executives and leadership teams across public, private, nonprofit, and multi-industry sectors to align talent strategy with business growth. On this episode, Dr. Cynthia explains her research findings on the ROI when investing in talent.Listen as Dr. Cynthia shares:- how to align talent strategy with business growth- what leads to cultural transformations- transforming people into a company's biggest competitive advantage- business outcomes vs human-centered leadership- how CEOs can unlock untapped value- the returns on intentional investments in talent- how to navigate career restlessness or stagnation- the leadership dilemma of empathy vs accountability...and so much more!Connect with Dr. Cynthia:Website: https://www.bentzenperformancepartners.comAdditional Resources:"Now, Near, Next" by Dr. Cynthia Bentsen-Mercer on AmazonListen to the Podcast, subscribe, leave a rating and a review:Apple: https://podcasts.apple.com/us/podcast/how-leaders-can-attract-and-retain-the-best-talent-w/id1614151066?i=1000741811750Spotify: YouTube: https://youtu.be/w9WFLhFzJd8

Tech analyst and journalist Carmi Levy can be heard regularly on Montreal Now with Aaron Rand as well as CTV News.

Pete and Sam recap the last week in CFB news, the epic Army-Navy contest, talk about the latest Virginia Tech coaching hires, and preview bowl season/the playoff.

Welcome to this bonus podcast episode! If you've ever looked at your red-hot competitors and wondered about their secrets to success, we've got you. Spoiler: it's not money, tech…or magic.  Coaches Caroline Plambeck and Rachel Prairie break down the simple, smart moves that create momentum in Episode 694: What Other Studio Owners Are Doing That You Are Not.  Share the why: host regular team meetings to build communication and buy-in Sell with soul: train your team to connect naturally and ditch pressure tactics Treat them right: onboard well and share opportunities to maximize retention   Guard your time: block hours to think big picture, plan ahead and get out of the weeds Track and tweak: scrutinize your data, refine and experiment without fear You don't have to overhaul everything. Start by excelling in the basics: know your numbers, empower your team and lead with clarity rather than chaos. Episode 694 is your overview.. Catch you there,   Lise   PS: Join 2,000+ studio owners who've decided to take control of their studio business and build their freedom empire. Subscribe HERE and join the party! www.studiogrow.co www.linkedin.com/company/studio-growco/ Top studios don't rely on luck, trends, or chaos—they rely on rhythm, clarity, and consistent follow-through. Start with five small shifts, put them into practice, and suddenly you're operating like the studios everyone else is trying to learn from.      

The Buck Reising Show Hr 3 - Which coaches should the Titans retain + Yahoo Sports' Jason Fitz, See omnystudio.com/listener for privacy information.

The Buck Reising Show Hr 3 - Which coaches should the Titans retain + Yahoo Sports' Jason Fitz, See omnystudio.com/listener for privacy information.

Georgia has great opportunity to get healthy with down time. Why Kaden Ellis is Falcons most important free agent to have back in 2026.

While it is not always referred to as a "1099 model", there is a type of RIA platform offering that many advisors find to be an attractive alternative to running their own RIA.These "1099 models" come in various flavors but they typically share the following (among other things):Retain 100% ownership of your practice;Use your own brand;Control your local expenses;Access a suite of technology and solution provider resources;If applicable, provide solutions for your remaining legacy commission assets; etc.If considering starting your own RIA, it's worthwhile understanding how these models compare.In this episode (#138) of the Transition To RIA question & answer series I explain what these models are and why they're worth considering for your practice.Come take a listen!P.S. Prefer video? You can find this entire series in video format on Youtube. Search for the TRANSITION TO RIA channel.Show notes: https://TransitionToRIA.com/what-is-a-1099-ria-model/About Host: Brad Wales is the founder of Transition To RIA, where he helps financial advisors between $50M and $1B understand everything there is to know about WHY and HOW to transition their practice to the Registered Investment Advisor (RIA) model. Brad has 20+ years of industry experience, including direct RIA related roles in Compliance, Finance and Business Development. He has an MBA and has held the 4, 7, 24, 63 & 65 licenses. The Transition To RIA website (TransitionToRIA.com) has a large catalog of free videos, articles, whitepapers, as well as other resources to help advisors understand the RIA model and how it would apply to their unique circumstances.

If there's one thing more painful than seeing Canada lose to the Americans in hockey, it's seeing promising Canadian companies pull up stakes and move south of the border. Canadian editors are in a dictionary dispute with the Carney government.

Download the 2024 BFS Strength Report for all of the details from the conversation, plus insights we didn't have time to cover. Also take the BFS Business Assessment (in partnership with BFU) to receive your individualized BFS Scorecard, a data-backed snapshot of how your studio compares to industry benchmarks across the KPIs that matter most (lead volume, conversion, recurring revenue, churn, and LTV).

It's Thursday, and you know what that means! It is time to walk through those Tavern doors and order up a round of professional wrestling coverage from The Two Bad Chads! This week we talk AEW and all the happenings of the week! Make sure you go to patreon.com/theturnbuckletavern for all your Tavern needs!

Guests Dr. Andrea Necchi, Dr. Ashish Kamat and host Dr. Davide Soldato discuss JCO article "End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer," focusing on the evolving treatment landscape of MIBC (muscle-invasive bladder cancer) and the need to properly design novel trials investigating non-operative management while including the incorporation of biomarkers and patient perspectives in clinical trials. TRANSCRIPT The disclosures for guests on this podcast can be found in the show notes. Dr. Davide Soldato: Hello and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, medical oncologist at Ospedale San Martino in Genoa, Italy. Today we are joined by JCO authors Andrea Necchi, Associate Professor of Medical Oncology at University San Raffaele and Medical Oncology at Ospedale San Raffaele in Milan, Italy, and Ashish Kamat, Professor of Urologic Oncology and Cancer Research at University of Texas MD Anderson Cancer Center. Both Professor Necchi and Professor Kamat are internationally recognized experts in the field of genitourinary malignancy and particularly in bladder cancer. Today we will be discussing the article titled "Endpoints for the Next Generation Bladder-Sparing Perioperative Trials for Patients with Muscle-Invasive Bladder Cancer." So thank you for speaking with us, Professor Necchi and Professor Kamat. Dr. Andrea Necchi: Thank you, Davide, and thank you JCO for the opportunity. Dr. Ashish Kamat: Yeah, absolutely. It is a great honor and privilege to be discussing this very important article with you. So thank you for the invitation. Dr. Davide Soldato: The article that you just published in JCO reports the results of a consensus meeting that was held among experts in the field of genitourinary malignancy and particularly for bladder cancer. So the objective was really to define endpoints for a novel generation of trials among patients diagnosed with muscle-invasive bladder cancer. So my first question would be: what is the change in clinical practice and in clinical evidence that we have right now that prompted the start of such consensus in 2025? Dr. Andrea Necchi: So, we are living so many changes in the treatment paradigm of patients with muscle-invasive bladder cancer. In general, patients diagnosed with bladder cancer or urothelial cancer today, thanks to the advent of immunotherapy or immunotherapy combinations, and today thanks to the advent of novel antibody-drug conjugates like enfortumab vedotin in combination with immunotherapy that are actually changing the landscape of treatment of patients with metastatic disease and also are entering quite fast into the treatment paradigm of patients with organ-confined disease with a lot of clinical trials testing these combination therapies, neoadjuvantly or adjuvantly, before or after radical cystectomy. Having said that, by potentiating the efficacy of systemic therapy, an increasing number of patients that receive neoadjuvant therapy of any kind, at a certain point in time, result to have achieved a deep response to systemic therapy, evaluated radiologically with conventional imaging, CT scan or MRI, or with cystoscopy or with other urology-based techniques, urinary cytology, and so. And based on the fact that they achieve a complete response, so no residual viable disease after systemic therapy, they raise concern about the fact that they have to undergo surgery like radical cystectomy that is quite impactful for their quality of life and for the future of their lives after the surgery. So the point that the patients are raising, and the patients are raising this point, is primarily due to the efficacy of systemic therapy. And we have seen so many cases fortunately achieving a deep response. So the question about what to do with the patient that at a certain point, at the start with the commitment to radical cystectomy, but at a certain point in time change their mind towards something else if possible, depending on the fact that they have achieved a deep response, is something that is a question and is a need to which we have to provide data, information, and guidance in general to the patients. Dr. Davide Soldato: If we look at the population that the recommendations were formulated for, we are mainly speaking about patients who would be fit for cystectomy, and this is a very distinct population compared to those who are not fit for cystectomy, both from a medical oncology point of view but also from a urologic point of view in terms of surgery. So, can you explain a little bit to our listeners why you think that this distinction is critical and why you developed this recommendation especially for this population? Dr. Ashish Kamat: That is a very important distinction that you made. To build upon what Professor Necchi mentioned earlier, this question that we get from patients after neoadjuvant therapy or systemic therapy is not a new question. It has been something that they have been asking us for the last 20 or 30 years. "Do I really need to have my bladder taken out?" And patients who are especially not fit for surgery will sometimes say, "Do I need to have my bladder taken out? And if I cannot have my bladder taken out, am I going to just not have anything done?" Because the eligibility for radical cystectomy is also a moving target. Over the years with improvement in surgical technique, improvement in perioperative therapy, ERAS protocols, et cetera, it is really unusual for us to deny a patient the opportunity to have major surgery unless clearly they have very significant comorbid conditions. So I think this endeavor is more broadly encompassing of the patient population than what was evident in previous years. And I really want to give a shout out to Professor Necchi because what we did was, as part of the International Bladder Cancer Group and Professor Necchi is an integral part of the scientific advisory board, we broached this topic broadly during one of our discussions. And of course, Andrea always does this, he picks on a topic and then he says, "Okay, we need to discuss this really in detail," put together a multinational, multicenter collaborative group, but the driving force was our patients. Because our patients are constantly asking, "Do I need to lose my organ? Do I need to have radiation therapy?" which again, also, has a lot of side effects. So this was really to answer the question in today's day and age as to do we need to do local consolidation, and if so, in what way? It is not a new question, but we have newer therapies, newer technology, and better ways to answer this. So it is a much needed question that needs to be answered. And I think the distinction between non-surgical candidates and surgical candidates is a little bit blurred in today's day and age. Dr. Davide Soldato: What about the eligibility, for example, for cisplatin-based chemotherapy? Because I think that that is a very fundamental part of this type of strategy that we apply to patients with muscle-invasive bladder cancer. So we know that there are some caveats for proposing such treatment. And also this population was specifically defined inside this recommendation. Dr. Andrea Necchi: I think that the focus of our work is just to analyze what is happening after any type of systemic therapy the patient may get neoadjuvantly. So it is not actually a question of treatment eligibility or including cisplatin eligibility. This is an old question of today's practice and clinical trials. But regardless of what the patient received neoadjuvantly, the point that we have addressed in our consensus meeting was what to do next as a further step after systemic therapy or not. So basically we are- the consensus guidance includes all-comers, so patients to get any type of systemic therapy. So really non-selected based on specific features that determine a special eligibility to a special or a particular therapy. But an all-comer approach is always the winning approach for the translation to be in practice, an all-comer approach just focusing on what has happened after treatment and that we are assessing by the use of conventional imaging, MRI or CT, cystoscopy, urinary cytology, and trying to merge all together this information, all these features in a unique, shared, reliable definition of clinical complete response that could be used as a biomarker for the selection of newer therapies instead of pathological response that has been historically used, and maybe surrogate for the outcome, the long-term outcome and survival of these patients. Dr. Davide Soldato: A very specific point of the consensus was actually the definition of clinical complete response. As you were saying, this is actually a combination of several parameters including urinary cytology, the use of cross-sectional imaging, for example CT scan, but also the evaluation in cystoscopy of the bladder. Do you foresee any potential problems when applying this type of recommendation, not inside clinical trials, but in the context of routine clinical practice? Dr. Ashish Kamat: Absolutely. And that was the whole reason we had this consensus meeting. What happens nowadays in daily practice, and we see this every day at our center, we see patients referred to us. This definition or this sort of attempt to define clinical complete response is an ongoing issue. And urologists, medical oncologists, radiation oncologists are always looking to see, does my patient have a complete response? That definition and those paradigms have changed and evolved over the years. The FDA had a workshop many years ago looking at this very question. And it was to address the proposal that complete clinical response, which is a clinical definition, a clinical state, does this correlate with pathologic response? And with the technology and the systemic therapies we had then, the answer was 'no'. In fact, more patients got recurrent disease than did not get recurrent disease. And that is why, of course in the paper we mention the trials that looked at this question, the trials that evolved around this question. And I think the distinction between a clinical trial and daily practice is extremely important when we are looking at this definition per se. Because essentially what happens with this issue is that if the patient is not appropriately counseled, and if the physician does not do the appropriate clinical complete response assessment as Professor Necchi mentioned, right, cystoscopy, cytology, imaging, use of markers that are still in evolvement, we risk doing harm to the patient. So we caution in the paper too that this definition is not ready for prime time use. It is something that needs to be studied. It is a rigorous definition and currently we are recommending it for clinical trials. I am sure eventually it will trickle down into clinical practice, but that guidance was not the purpose of this consensus meeting. Dr. Davide Soldato: There are several parameters that are potentially evolving and could potentially enter inside of clinical practice. For example, you mentioned pelvic MRI and we have now very specific criteria, the VI-RADS criteria, we're able actually to diagnose and also to provide information. So along with these novel imaging techniques, we also know that there are novel biomarkers that could be explored, for example ctDNA and urinary DNA. So what I was wondering is, why were not these included inside the definition that you provide for clinical complete response? And do you think that, as we are designing these trials to potentially spare cystectomy for this patient, we should include these biomarkers very early so that we can actually provide better stratification for our patients and really propose this type of cystectomy-sparing strategy only to those where we are very confident that we have obtained a clinical complete response? Dr. Andrea Necchi: I would say you have just to wait. So a follow-up is ongoing and hard work is ongoing. At the time we met, at the time we established the meeting in mid-December last year, we had no information on the ctDNA data from major trials, with only a few exceptions. So we were just at the beginning of a story that was more than likely to change but still without numbers and without data from clinical trials. Now in just nine months or 10 months time, we have accumulated important data and newer data will be presented during just a few weeks and a few days regarding the ctDNA, circulating tumor DNA in particular, as a prognostic marker assessed baseline or assessed after neoadjuvant therapy. So the point is certainly well made and ctDNA is certainly well shaped to be incorporated in a future definition of clinical complete response. But you have to consider the fact that most of the data that we are accumulating related to ctDNA are about the post-cystectomy field or the metastatic field. So regarding neoadjuvant therapy, you know, we have neoadjuvant therapy in the context of bladder-sparing approach, basically we have no information. And the point that is emerging in our daily practice when using these biomarkers or in clinical trials, and the impression in general, is that it is a very strong biomarker associated with survival, but we absolutely do not know what is the performance of the test in the prediction of superficial bladder relapses, high-grade pTa relapse in the bladder that is left untouched in the patient. We are considering, and maybe it will be just a matter of further discussion, not just what is happening within the immediate endpoint of clinical CR, but also what is happening later with other survival endpoints. And for example, when looking at the type of events that we may see in this kind of bladder-sparing approaches, most of the events, also in the trials that have been published including the RETAIN study published in JCO, most of the events are related to superficial high-grade superficial non-muscle invasive relapses. So the ability to predict these types of events with ctDNA is completely unknown. Maybe, maybe other liquid biomarkers like urinary tumor DNA, utDNA, could be a bit better shaped in the prediction of this kind of events, you know. But we have still to build the story. So the question is good. The answer is yes, we will likely, more than likely incorporate liquid biomarkers in the definition, but we have to wait at least more data and more robust data in order to translate this information in routine practice, you know. Another consensus meeting is organized by IBCG and the same folks for November. This meeting will be primarily focused on the liquid biomarkers, the interpretation and use and approval and so of liquid biomarkers including bladder cancer. And we will likely be able to address all these, most of these open issues, so most of these points in the next meetings. Dr. Davide Soldato: In the consensus you say that probably clinical complete response is now ready to be included in early phase trials, so actually to test what is the efficacy of the regimens that is being evaluated inside of these trials. But you actually do very in-depth work of defining what are the most appropriate endpoints for later phase trials. So to be very specific, the phase three registrational trials that bring new regimens inside of this space. So I just wanted to hear a little bit about what was the definition for event-free survival, which you define as the most appropriate one for this type of trials. And as you were mentioning before, Professor Necchi, there is a very specific interest on the type of events that we observe, especially when we look at these superficial relapses inside of the bladder. So was this a very urgent matter of debate as we define which type of events should actually trigger event-free survival? And did you make a very thoughtful decision about why using this type of endpoint instead of others, for example metastasis-free survival? Dr. Ashish Kamat: Yeah, this was a matter of intense debate as you might imagine. And again, this is a moving target. So as Professor Necchi mentioned, we tend to partner with each other, our organizations, on having definitions of clinical complete response, biomarker, retreats, and then using that as a marker, and you might imagine this definition of what is appropriate event-free survival, what events matter to the patient, is something we have been talking about for two years. It was not just something that came up at the retreat. But at the retreat there was intense discussion. One of the things that we talked about was bladder-intact event-free survival because we are trying to spare the patient's bladder. And do we count bladder-intact event-free survival as something that is relevant? The patient advocates absolutely liked that, right? They wanted that. But then we also learned from some of the studies, for example from the RETAIN study, that the non-muscle invasive recurrences can actually lead to metastatic disease. It is not as benign when you have a patient with muscle-invasive bladder cancer that then develops a non-invasive tumor because maybe there is cancer growing underneath the surface that we don't detect when we look in the bladder. So a lot of those discussions were held, debated. It was a consensus. I have to say it was not 100% agreement on that particular definition, but it was broad consensus. And Andrea, do you want to clarify a little bit as to how we came about that consensus? Because I think this is a very important point we need to make. Dr. Andrea Necchi: We focused on a bit different definition of BI-EFS, Bladder-Intact Event-Free survival. Just stating EFS as an all-inclusive parameter including all type of high-grade relapse or progression or death that may happen to the patient. So that we were counting high-grade pTa, pT1, CIS relapses to the bladder and of course more deeper involvement in the muscle layer and so, and metastatic disease as a relapse. But the point is that as compared to the classical bladder-intact EFS definition of chemoradiation bladder-sparing approaches that is including muscle-invasive relapses only or death as events, we tried to be as inclusive as possible in order to be as much conservative as possible and to raise as higher the bar as possible for the success. And this is actually what the patients are asking us. So they are asking, "Okay, I can save my bladder, sparing radical cystectomy, but at which cost?" So in order to provide an answer, we have to be very, very cautious and be on the right shape, on the right position to say, "Okay, we have accomplished the most, the safest points, you know, by which you can proceed with the bladder-sparing." This is the first point. The other point is related to the MFS, metastasis-free survival that you have mentioned. For sure, it was recognized as a very important point for sure. But in the discussion was clear that our focus was in saving patients, curing the patient, and saving the bladder. Any single event, superficial event that may occur in the bladder-saving approaches of this kind may expose the patient to an extra risk of developing distant metastases, as it happened for example in the RETAIN study. So EFS defined as we have agreed and published, is actually a way of including or anticipating in a safest position the MFS. Because most or if not the entirety of the events of metastasis development in patients undergoing bladder-sparing after neoadjuvant systemic therapy were preceded by a superficial phase of disease relapse, you know. So I remember very, very few, or we can count just on the finger of one hand, the cases that have been reported in the literature developing de novo metastatic disease in the similar bladder-sparing approaches, in particular when using a maintenance immunotherapy strategy, you know, after they reach TURBT. So this is the reason why with all the limitation that Ashish has mentioned, with all the uncertainties that are still there, the nervousness that is still there, EFS, as defined in the protocol, as put in the paper, is to us at the moment is the safest way to use a primary endpoint in potentially registration trials of this kind with perioperative systemic therapy and response-adapted surgery. Dr. Ashish Kamat: And David, just to be absolutely clear for our listeners, right, so what was the event-free survival that we defined? Essentially it was a very inclusive definition. Event was defined as high-grade tumor persistence, recurrence, or progression during or after perioperative therapy, and receipt of any additional standard of care treatment including radical cystectomy, radiotherapy or even intravesical therapy. So this was done at the behest of our patient advocates because we really wanted to make a very robust definition that could be utilized appropriately as an adequate primary endpoint for both early and late phase bladder preservation trials. Dr. Davide Soldato: I think that it really highlights one of the points that I liked the most about this consensus is that it really incorporated the patient vision and a sort of shared decision making process when we are deciding how we want to design these trials that will explore this bladder-sparing surgery. And Professor Necchi mentioned something that I think will be also a very interesting question for trials that will be developed considering the activity of this combination that we are seeing right now, which is maintenance. Because right now our approach in the few cases where patients do not do any type of treatments after an induction with neoadjuvant treatments is basically represented by observation. So I was wondering if you think that the field will actually evolve to a sort of maintenance strategy even in patients that will achieve a complete clinical response? Dr. Andrea Necchi: We just mentioned briefly in the paper, this is a very important point that was touched during the discussion, and in particular was raised and discussed by FDA people participating in the meeting. And when looking at the data from the trials that were available and are still available thus far, we could provide a suggestion that maintenance immune therapy is the preferred approach in this kind of approach as it currently stands, as the data currently stand. Because the cleanest data towards the successful part of this journey is related to the studies that provided a kind of maintenance therapy, like the study with nivolumab or the RETAIN-2 study with maintenance immune therapy instead of RETAIN study that was just stopping treatment until surgery with MVAC chemotherapy. So in general the impression is that maintenance therapy may help in reducing the type of events, including the events that we incorporate in the EFS definition that we mentioned in the paper. The point that you mentioned is very important because on the other side we have a problem, a big problem of affordability and cost of the treatment. The de-escalation trials are an urgent need and represent a call for the studies. Unfortunately, as you mentioned, this is something that moves beyond the possibilities of this type of consensus because we don't have data and we have to accumulate data from clinical trials prior to saying, "Okay, certain patients could de-escalate therapy and stop therapy and some other not." So we are still at the very beginning. So we can do- we can discuss about this in the radical cystectomy paradigm but not in the bladder-sparing paradigm, you know. But this is for sure a point, a discussion point that will be taken, pretty well taken in one year or two year projection. Dr. Davide Soldato: I was wondering if in the consensus, considering that patient advocates and patient associations were also involved, did you decide to actually suggest the inclusion of patient-reported outcomes or the evaluation of shared decision-making in the development of this trial really as endpoints that should matter as much or as much as possible as event-free survival and clinical complete response? Dr. Ashish Kamat: Oh yeah, absolutely. We had patient advocates, we had the World Bladder Cancer Patient Coalition, Bladder Cancer Advocacy Network, patient representatives. And we always consider this. Shared decision-making is actually the impetus behind why these efforts have been launched, right? So it is the shared decision-making that is very, very important. It is the driving force behind what we do. And it is worth noting, for example, for the design of such studies, regulatory agencies consider response-based endpoints or overall survival as primary endpoints. But the patient advocates consider quality of life to be just as important, if not more important sometimes than overall survival numbers. Because patient advocates will say, "Well if I live longer but I'm miserable living longer, yes that works for regulatory agencies but doesn't work for us." So PROs clearly are very, very important. And, in fact, we just literally had a meeting in Houston, the IBCG meeting where PROs were a main point of what we discussed. So incorporating PROs in everything we do, not just this but everything we do, Dr. Necchi, myself, everybody involved in these fields realizes it is very, very important. So absolutely. Dr. Davide Soldato: I want to thank again Professor Necchi and Professor Kamat for joining us today. Dr. Andrea Necchi: Thank you. Dr. Ashish Kamat: It is our pleasure. Dr. Davide Soldato: Thanks again and we appreciate you sharing more on your JCO article titled "Endpoints for the Next Generation Bladder-Sparing Perioperative Trials for Patients with Muscle-Invasive Bladder Cancer." If you enjoy our show, please leave us a rating and review and be sure to come back for another episode. You can find all ASCO shows at asco.org/podcast. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

Today's economic and geopolitical volatility can cause uncertainty even among the best business plans. Focus on what you can control in your studio to navigate these waves.  Join Business Coach Matt Hanton and me in this series for in-the-trenches insights on how to stay steady in the storm, starting with Episode 691: Your Economy-Proof Plan, Part 1.  Be the best: cultivate operational excellence in every experience Invest in impressions: train your front desk staff to provide 5-star touchpoints Slip into their world: connect beyond the studio thoughtfully, personally and digitally  Retain your A-team: develop and reward your superstars to maintain loyalty  Lead with heart: foster clarity and confidence for your team and members Keep in mind that even when the world wobbles, people still crave and prioritize health, well-being and belonging. Discover how your studio can nurture all three in Episode 691. Catch you there,   Lise   PS: Join 2,000+ studio owners who've decided to take control of their studio business and build their freedom empire. Subscribe HERE and join the party! www.studiogrow.co www.linkedin.com/company/studio-growco/  

Ed, Rob, and Jeremy took some time from the second hour of Thursday's BBMS to discuss Mike Tomlin's job future with the Steelers, as the calls for his job grow louder and louder from fans and pundits. Despite the noise, the players have shown they still support him, but is that enough for the Steelers to keep him?

Janice Litvin is one of America's leading experts on Workplace Wellness and Beating Burnout. Janice will show us exactly how to help others stop burnout before it starts — with simple, science-based techniques to manage stress, reset our thinking, and build stronger resilience at work and at home. She'll give us practical tools we can use immediately, including her signature “pause–reflect–reset” method that has helped thousands of professionals stay calmer, clearer, and more in control.

It's the end of the year, do you know how your employees are really performing? In this episode, host Melissa Franks walks you through exactly what business owners should be doing in the final stretch of the year to evaluate their team, strengthen retention, and prepare for a smooth start to the new year.Drawing from her experience as a Fractional COO, Melissa breaks down a simple, actionable framework that replaces corporate-style performance reviews with a more human, results-driven approach designed for small business owners.In this episode, you'll learn:✅ How to calculate total employee compensation (and why it's more than just salary).

Chip Scoggins, Ryan Burns and Justin Gaard are back to recap a snowy afternoon in Minneapolis where the Gophers won Paul Bunyan's Axe for the 4th time in 5 years. The guys discuss what the right evaluation is for a 7-5 season and what the big picture outlook is with Drake Lindsay potentially leading the offense the next few years. The Lane Kiffin domino fell to LSU over the weekend, they talk about how that went down and what it means and meant for the rest of the coaches carousel. See omnystudio.com/listener for privacy information.

#697 Want to build a team that sticks with you, performs at a high level, and actually loves coming to work? Samantha Irwin — owner of Kaizen Coaching and Consulting and longtime friend of the show — returns for a deep dive into the art and science of employee retention! In this episode hosted by Brien Gearin, she shares her journey from middle-school teacher to historic hotel owner to leadership coach, revealing the people-first systems she used to build a loyal, high-performing team in a town of just 650 residents. Samantha breaks down her three-part framework for attracting the right employees, training them well, and retaining them through appreciation and strong culture. Whether you're hiring your first contractor or growing a team, her strategies will help you create a workplace where great people stay and thrive! What we discuss with Samantha: + Samantha's hotel ownership origin + Attracting the right employees + Training with clear roadmaps + Retention through appreciation + Importance of company culture + Hiring for personality first + Onboarding with intentional structure + Incentives beyond money + Turning staff into thinkers + Leadership vs. boss mindset Thank you, Samantha! Check out Zaizen Coaching and Consulting at Zaizen.zone. Buy The Power of People Academy, Module 1: First Impressions. Follow Samantha on LinkedIn. Watch the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠video podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ of this episode! To get access to our FREE Business Training course go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠MillionaireUniversity.com/training⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. And follow us on: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Tik Tok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ To get exclusive offers mentioned in this episode and to support the show, visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠millionaireuniversity.com/sponsors⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Learn more about your ad choices. Visit megaphone.fm/adchoices

That Solo Life, Episode 323: How to Identify, Land, and Retain Sponsorship Deals Episode Summary In this episode, Karen Swim, APR, and Michelle Kane welcome back Anetra Henry, founder of Anetra Henry Consulting. Anetra brings her expertise in nonprofit sponsorships to the table, guiding solo PR pros and communicators through each step of the sponsorship journey. The conversation covers the essentials: identifying aligned sponsors, developing sustainable strategies, managing relationships, and understanding the real costs and rewards of sponsorship. Whether you're new to sponsorship deals or want to deepen your approach, this episode is packed with insights, practical advice, and wisdom from the frontlines of nonprofit development and communications. Episode Highlights [01:13] Anetra shares her career update and the relaunch of Anetra Henry Consulting, focusing on helping nonprofits secure sustainable revenue through corporate sponsorships. [03:32] Adjusting sponsorship strategies in the face of industry shifts and navigating workforce and philanthropy changes. [04:39] Why most nonprofits overlook ongoing sponsor relationships and the pitfalls of only thinking about annual galas. [05:08] Viewing corporate sponsorship as a reliable stream of income and integrating it into long-term planning. [06:05] The communicator's role in sponsorship: leveraging storytelling and impact reports to retain and nurture sponsors. [09:10] Managing PR crises and evaluating potential sponsors: assessing reputational risk and the importance of thorough vetting. [14:30] The four most common sponsor “personality types” and how to work effectively with each: The Fisher, The Decisive, The Egocentric, and The Infiltrator. [19:39] Understanding the true cost of sponsorship management for nonprofits and associations—what every dollar really takes to earn. [22:57] Are nonprofits embracing AI? The current landscape and smart ways to use AI for prospecting and admin without losing a human touch. [26:09] Balancing the heart and business of nonprofit work: reminders for communicators and PR pros who serve mission-driven organizations. [28:47] Anetra's advice for listeners: take care of yourself, know your value, and support nonprofits while maintaining sustainable business practices. [28:48] How to connect with Anetra: her website, LinkedIn, and book for practical guidance on sponsorship success. About Anetra Henry Anetra Henry is the founder of Anetra Henry Consulting, where she helps nonprofits and associations secure strategic, sustainable corporate sponsorships. With over 20 years of experience in nonprofit growth, sponsorship strategy, and communication, Anetra partners with organizations to develop actionable plans that bolster revenue and impact. She is also the author of the “Sponsorship Success Guide,” designed for purpose-driven teams seeking reliable funding and practical tools. Please connect with Anetra on LinkedIn.   Related Episodes & Additional Information Get your copy of Anetra's book: Sponsorship Success Guide Episode 254: The Work of Diversity, A Conversation with Anetra Henry Host & Show Info That Solo Life is a podcast created for public relations, communication, and marketing professionals who work as independent and small practitioners. Hosted by Karen Swim, APR, founder of Words For Hire and President of Solo PR Pro, and Michelle Kane, Principal of Voice Matters, the show delivers expert insights, encouragement, and advice for solo PR pros navigating today's dynamic professional landscape. Enjoyed this episode? Let us know! Subscribe and leave us a five-star review on Apple Podcasts, Spotify, or your favorite platform. Share this episode with your colleagues, connect with Anetra for more support, and help us empower more Solo pros to thrive in their businesses and communities.

Episode Title: Rain Sounds for Studying: Boost Your Memory and FocusDescription:In this episode of Thunderstorm: Sleep and Relax in the Rain, we explore how the gentle sound of rain can enhance your study sessions and improve information retention. Immerse yourself in soothing rain sounds designed to create a calm, distraction-free environment that helps your brain absorb and recall information more effectively.As you listen, imagine yourself in a peaceful rain-soaked setting where every drop encourages concentration and clarity. Whether you're preparing for an exam or working on a challenging project, these rain sounds serve as the perfect background to sharpen your focus and deepen your learning experience.Let the natural rhythm of rain wash away distractions and support your mental clarity. Tune in now and discover how the calming ambiance of rainfall can transform your study routine into a session of calm productivity.DISCLAIMER

Joel (@JoelPearl) and Phil (@PhilDL616) bring you tonight's Survivor Series Post Show, November 29, 2025, including:Women's WarGames: Rhea Ripley, Iyo Sky, Charlotte Flair, Alexa Bliss & AJ Lee vs. Asuka, Kairi Sane, Nia Jax, Lash Legend & Becky LynchWomen's World Championship: Stephanie Vaquer (c) vs. Nikki BellaIntercontinental Championship: John Cena (c) vs. Dominik MysterioMen's WarGames: CM Punk, Cody Rhodes, Roman Reigns, Jey Uso & Jimmy Uso vs. Bron Breakker, Bronson Reed, Logan Paul, Drew McIntyre & Brock Lesnar   Grab your EXCLUSIVE NordVPN Deal by going to http://nordvpn.com/fightful to get a Huge Discount off your NordVPN Plan + a Bonus Gift! It's completely risk free with Nord's 30 day money-back guarantee! ➼ https://nordvpn.com/fightful Try it risk-free now with a 30-day money-back guarantee! If you want to bet on Wrestling, or any other sport, check out our new partner where we get ALL of our odds! https://mybookie.website/joinwithFIGH... and use the promo code FIGHTFUL. Deposit $100, get $50. Go in with $200, and they'll make it $100! Get the best night's sleep of your life and 100 nights risk free on a great mattress with http://HelixSleep.com/Fightful!Explore the podcast  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

John McMahon is widely regarded as one of the greatest enterprise-software sales leaders of all time. He's the only person to have served as Chief Revenue Officer at five public software companies: PTC, GeoTel, Ariba, BladeLogic and BMC Software. He helped scale BladeLogic from a startup into a public company — ultimately leading to its ~$880M sale to BMC — and drove GeoTel into a multi-billion dollar acquisition. Today he sits on the boards of top names such as Snowflake and MongoDB, while also mentoring and influencing a who's-who of modern SaaS sales leaders. AGENDA: 03:33 The Art and Science of Sales: Insights from a Veteran 04:29 Adapting Sales Strategies in the Age of AI and PLG 07:47 The Ultimate Framework to do Deal Qualification 14:13 How to Drive Urgency and Maintain Sales Process 20:06 How to Hire the Best Sales Reps 25:11 Step-by-Step Guide to Training Sales Reps 45:22 The Mindset of the Best Sales Reps 54:55 Single Most Important Skill to Win in Sales  

In this episode, Kirk Teachout and Zach Shelley dive into what truly drives hygiene retention in a thriving dental practice. They explore how clear communication, collaborative teamwork, and ongoing education can strengthen your hygiene department and reduce turnover. From breaking down role-based silos to empowering the front office for smoother operations, this conversation highlights practical strategies for building a supportive, growth-focused culture. Discover how investing in your team leads to loyal hygienists, stronger relationships, and long-term practice success.

In Episode 3 of the Podcast we breakdown some common reasons why you aren't retaining clients. Trust me, I've been there! I know this short podcast will add value to your business, in any stage.

In the final episode of the CEO Diaries series, Jill discusses one of the trickiest parts of running a successful membership: retention. She breaks down why people actually cancel—usually because they're not using the membership or they feel overwhelmed—and shares how to keep members engaged through clear roadmaps, early wins, simple monthly cadences, and purposeful community-building. Jill explains the psychology behind recurring payments, why "just giving more stuff" backfires, how to design a Goldilocks amount of content, and why fostering peer-to-peer interaction creates true ownership and longevity.     Get on the wait list for the Strategy Lab! https://jillfitfree.com/strategy-lab-wait-list/   Jill is a fitness professional and business coach who effectively made the transition from training clients in person and having no time to build anything else to training clients online and actually being more successful. Today, Jill helps other coaches to do the same.   Connect with me! Instagram: @jillfit | @fitbizu Facebook: @jillfit Website: jillfit.com               membership, retention, psychology, consumer behavior, financial commitment, engagement

In 2024, Cindy's book about her and Mark's experiences living a full-time Van life was published by One Stone Biblical Resources. It is entitled One Hundred Churches: A Three-Year Journey to Witness the Joy of Authentic Christianity. The book is part travel journal, part spiritual roadmap, part autobiography, part devotional, and part vanlife guide.Come along for the ride as Cindy shares the encouraging and informative stories from her book that some of her readers are calling "addictive".

FSU Announces Decision to Retain Mike Norvell.If you're listening on Apple Podcasts, make sure you subscribe so you do not miss any new episodes. Feel free to rate us 5-stars and leave a review, it helps a lot! Join our Patreon to receive insider scoop 24/7: https://www.patreon.com/NoleGamedayJoin thousands of FSU fans in our Discord for FREE: https://discord.gg/sUGqPQnFollow the guys on Twitter:Show - @HearTheSpearAustin - @NolesVikesVeazDustin - @Dussttin Logan - @LogansTwittyAdvertising Inquiries: https://redcircle.com/brands

** Always looking for fantastic guests for upcoming shows - feel free to buzz me on 0414659800 to chat or

11.21.25 Hour 3, Ben Standig from The Last Man Standig Podcast joins The Kevin Sheehan Show to discuss the Jayden Daniels injury timeline for his possible return to play this season, upcoming free agents for the Commanders and how the team will close out the season. Kevin Sheehan gives you his smell test picks for this weekend's NFL and College Football games. Kevin Sheehan discusses the Commanders getting another international game in the 2026 NFL season.

11.21.25, Ben Standig from The Last Man Standig Podcast joins The Kevin Sheehan Show to discuss the Jayden Daniels injury timeline for his possible return to play this season, upcoming free agents for the Commanders and how the team will close out the season.

“Leadership is about the energy that we bring. Are we bringing a negative, toxic energy? Are we bringing an exhausted, burned out energy, a victim energy? Or are we bringing positivity and courage and empowerment?” – Alison C. Jones Today's featured #1 bestselling author is a mom, sustainable leadership strategist, keynote speaker, multi-certified Women's Leadership coach, and the CEO & Founder of GLOW (Growing the Leadership of Women) and Wellness Society LLC, Alison C. Jones. Alison and I had a fun on a bun chat about her book, “Character Leadership: How to Attract, Retain, and Energize Employees to Create a Winning Organization”, the concept of vessel leadership, and more! Key Things You'll Learn:What inspired Alison to become a published authorWhat she learned about herself through the book-writing processHow your mindset shapes your leadership styleThe five essential states of leadershipAlison's Site: https://www.alisoncjones.com/Alison's Book: https://a.co/d/4jqnXyUThe opening track is titled “Unknown From M.E. | Sonic Adventure 2 ~ City Pop Remix” by Iridium Beats. To listen to and download the full track, click the following link. https://www.patreon.com/posts/sonic-adventure-136084016 Please support today's podcast to keep this content coming! CashApp: $DomBrightmonDonate on PayPal: @DBrightmonBuy Me a Coffee: https://www.buymeacoffee.com/dombrightmonGet Going North T-Shirts, Stickers, and More: https://www.teepublic.com/stores/dom-brightmonThe Going North Advancement Compass: https://a.co/d/bA9awotYou May Also Like…Ep. 983 – How Neuroscience Can Fuel Your Book & Life Success with Sara Connell (@saracconnell): https://www.goingnorthpodcast.com/saracconnell/Ep. 851 – How To Be Future-fit and Lead With Relevance with Louise Mowbray (@louisemowbray): https://www.goingnorthpodcast.com/ep-851-how-to-be-future-fit-and-lead-with-relevance-with-louise-mowbray-louisemowbray/Ep. 889 – Every Day Is A New Day with Jenny Teeters, MBA (@JennyTeeters): https://www.goingnorthpodcast.com/ep-889-every-day-is-a-new-day-with-jenny-teeters-mba-jennyteeters/Ep. 667 – Pursuing Success God's Way with Erin Harrigan (@ErinHCoach): https://www.goingnorthpodcast.com/ep-667-pursuing-success-gods-way-with-erin-harrigan-erinhcoach/Ep. 887 – How to Unlock Your God-Given Destiny & Make Connections That Count with PJ Victor (@jenahsjourney): https://www.goingnorthpodcast.com/ep-887-how-to-unlock-your-god-given-destiny-make-connections-that-count-with-pj-victor-jenahs/Ep. 389 – Unshakable, Undaunted, & Undefeated with Elizabeth Meyers (@thelizmeyers): https://www.goingnorthpodcast.com/ep-389-unshakable-undaunted-undefeated/Ep. 810 – You Are Worthy with Katherine Norland (@katnorland): https://www.goingnorthpodcast.com/ep-810-you-are-worthy-with-katherine-norland-katnorland/Ep. 1002 – Why Living With Intention Is The Key to Mastering Life with Bianca D'Alessio: https://www.goingnorthpodcast.com/ep-1002-why-living-with-intention-is-the-key-to-mastering-life-with-bianca-dalessio/Ep. 309 – Home Worthy with Sandra Rinomato (@SandraRinomato): https://www.goingnorthpodcast.com/ep-309-home-worthy-with-sandra-rinomato-sandrarinomato/Ep. 517 – God's Not Done with You with Mary Guirovich (@maryguirovich): https://www.goingnorthpodcast.com/ep-517-gods-not-done-with-you-with-mary-guirovich-maryguirovich/Ep. 480 – Applying Your God-given Passions to Everyday Life with Marnie Swedberg (@MentorMarnie): https://www.goingnorthpodcast.com/ep-480-applying-your-god-given-passions-to-everyday-life-with-marnie-swedberg-mentormarnie/Ep. 680 – The Influence Lottery Ticket for Having High Impact with Kelly Swanson (@motivationspkr): https://www.goingnorthpodcast.com/ep-680-the-influence-lottery-ticket-for-having-high-impact-with-kelly-swanson-motivationspkr/Ep. 837 – Make Your Author emPact with Stephanie Feger (@stephaniefeger): https://www.goingnorthpodcast.com/ep-837-make-your-author-empact-with-stephanie-feger-stephaniefeger/

CBS Sports' Tom Fornelli reports that a good portion of Maryland fans believed there was a strong chance Franklin could be the next coach for the Terrapins before accepting the VA Tech job---he did spend 8 years as an assistant under Ralph Friedgen there and was deemed the ‘coach in waiting' before leaving for Vanderbilt in 2010 Lots has changed since 2010, so it's no surprise he's not ending up there…but that's some pain for that fanbase   Show Sponsored by NEBCOOur Sponsors:* Check out Avocado Green Mattress: https://avocadogreenmattress.com* Check out Hims: https://hims.com/EARLYBREAK* Check out Infinite Epigenetics: https://infiniteepigenetics.com/EARLYBREAK* Check out Uncommon Goods: https://uncommongoods.com/EARLYBREAK* Check out Washington Red Raspberries: https://redrazz.orgAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Carl and Mike get into some of the latest headlines as they share thoughts on reports of Lane Kiffin denying Ole Miss gave him an ultimatum in regards to if he plans to remain with the Rebels program or move on. As they discuss, Carl notes he believes Ole Miss needs to 'push every chip in' on an offer to Kiffin to prove to the fanbase they were willing to go all in on keeping Kiffin in Oxford.

As another tax year comes to a close, many successful business owners are undoubtedly asking themselves the same question: How do I keep more of what I've earned away from Uncle Sam this year?  In this episode, I'm sitting down with Bayntree's Director of Corporate Development, Brian Hartstein, to break down year-end strategies to help entrepreneurs and high-income earners make the most of their pre-tax dollars and reduce their biggest expense: Taxes. With over 30 years of experience collaborating with business owners, CPAs, and plan administrators, Brian has seen firsthand how many companies wait until the fourth quarter to address tax planning. He emphasizes the benefits of proactive planning and how it leads to significant savings and long-term wealth creation through strategies such as SEP IRAs, 401(k)s, profit-sharing plans, and cash balance pension plans. We'll also walk you through the Retirement Plan Pyramid, and demonstrate which tools make the most sense for different business stages—from solo entrepreneurs to companies with dozens of employees.  Whether looking to shelter high income before year-end or looking for ways to use retirement plans as a competitive advantage to recruit, retain, and reward top talent, this episode will help you identify smart, actionable ways to keep more of what you earn and build your retirement wealth strategically. In this podcast interview, you'll learn:  Why most business owners wait too long to plan—and how to avoid the "fourth-quarter fire drill." The most overlooked pre-tax opportunities that can save tens of thousands in taxes. How to choose between a SEP, SIMPLE, 401(k), or cash balance plan based on your business structure. The power of the Retirement Plan Pyramid and how each layer fits your financial goals. How to use retirement plans as recruitment and retention tools for key employees. Why being proactive—not reactive—with your CPA and advisor can make all the difference. Find All Interview Resources Here - www.bayntree.com/118 Download your copy of The Entrepreneur's Financial Planning Checklist

Hiring shouldn't feel like a revolving door. In this episode, Brian Gallagher reveals why so many PT practices struggle to keep great people — and how the most successful clinics retain loyal, productive, high-performing teams. Learn how to replace "task training" with a performance-driven culture built on purpose, clear structure, and meaningful accountability. When your staff understands their role, feels valued, and sees a future with your organization, retention becomes the norm — not the challenge. If you want to stop burnout, stop turnover, and start building a team that sticks… this episode is your blueprint.  

In part 2 of this episode of the HVAC Know It All Podcast, host Gary McCreadie is joined again by Joshua Canfield, owner of Blue Box HVACR, about the value of transformational coaching in the skilled trades. They discuss how empathy, patience, and clear communication can help new technicians grow and succeed. Joshua explains why older techs often struggle to connect with younger ones and how setting clear expectations can make a big difference. The conversation also covers using technology like remote video support to bridge training gaps and the idea of building hands-on trade schools that simulate real job pressure. This episode highlights key ways to support and teach the next generation of HVAC professionals. Gary and Joshua talk about how transformational coaching helps young HVAC techs grow by focusing on support instead of harsh criticism. They explain why many older techs struggle to connect with the new generation and how clear steps and respect can help both sides work better together. Joshua shares tips for training, like asking questions, watching closely, and staying off phones unless they help with learning. They also talk about hands-on trade schools, using real pressure situations, and tech tools like remote video support to guide new techs in the field. They finish by stressing the need for teamwork and better ways to train in today's HVAC industry. Expect to Learn: Why transformational coaching helps new HVAC techs grow with confidence.  How to bridge the gap between older and younger techs on the job.  Why asking clear questions builds respect and saves time.  Ways trade schools can train students under real pressure.  How remote video tools can support techs in the field from a distance.   Episode Highlights: [00:00] - Intro to Joshua Canfield in Part 02 [01:35] - What is "Transformational" Coaching? [03:47] - Joshua on transforming people [06:16] - Are young workers really lazy? [07:46] - Solving the generational gap [10:32] - Respect and phone usage [12:26] - A story on miscommunication [14:21] - The ideal trade school model [17:21] - Good vs. bad on-site experiences [19:07] - Using tech for remote training [22:57] - Conclusion & plans for future talks This Episode is Kindly Sponsored by: Master: https://www.master.ca/ Cintas: https://www.cintas.com/ Cool Air Products: https://www.coolairproducts.net/ property.com: https://mccreadie.property.com SupplyHouse: https://www.supplyhouse.com/tm Use promo code HKIA5 to get 5% off your first order at Supplyhouse! Follow the Guest Joshua Canfield on: LinkedIn: https://www.linkedin.com/in/joshua-canfield-32152a163/ Blue Box HVACR: https://www.linkedin.com/company/blue-box-hvacr/    Website:  Blue Box HVACR: https://blueboxhvacr.com/    Follow the Host: LinkedIn: https://www.linkedin.com/in/gary-mccreadie-38217a77/  Website: https://www.hvacknowitall.com Facebook: https://www.facebook.com/people/HVAC-Know-It-All-2/61569643061429/   Instagram: https://www.instagram.com/hvacknowitall1/ 

The Dadley Boyz chat about what happened on this week's episode of Monday Night RAW, including...Logan Paul joins The Vision!AJ Styles & Dragon Lee retain the tag titles!Raquel Rodriguez earns a title shot!Penta vs. El Grande Americano!Rey Mysterio 619's his son?!ENJOY!Follow us on Twitter:@AdamWilbourn@MichaelHamflett@MSidgwick@WhatCultureWWEFor more awesome content, check out: whatculture.com/wwe Hosted on Acast. See acast.com/privacy for more information.

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3791: Michael Mehlberg reveals how to transform reading from a passive habit into an active process that strengthens memory and sparks lasting personal growth. Through reflection, repetition, and practical application, he shows how to absorb ideas deeply enough to change the way you think and live. Read along with the original article(s) here: https://michaelmehlberg.com/blog/2015/6/29/reading-to-remember Quotes to ponder: "Reading isn't enough. You need to remember what you read if you want to make a difference in your life." "Your brain needs to process, connect, and repeat information before it becomes part of your thinking." "When you learn something new, it doesn't stick until you use it, reflect on it, and tie it to what you already know." Episode references: How to Read a Book: https://www.amazon.com/How-Read-Book-Classic-Intelligent/dp/0671212095 The Power of Habit: https://www.amazon.com/Power-Habit-What-Life-Business/dp/081298160X Moonwalking with Einstein: https://www.amazon.com/Moonwalking-Einstein-Science-Remembering-Everything/dp/0143120530 Learn more about your ad choices. Visit megaphone.fm/adchoices